Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,4 USD | +0,23% | -9,28% | +3,29% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 272 mln. 254 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -94 mln. -87,97 mln. | Nettowinst (verlies) 2025 * | -119 mln. -111 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-3,05
x | K/w-verhouding 2025 * |
-2,8
x | Werknemers | 59 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,34% |
Recentste transcriptie over Inozyme Pharma, Inc.
1 dag | +0,23% | ||
1 week | -9,28% | ||
Lopende maand | -42,56% | ||
1 maand | -24,14% | ||
3 maanden | -3,72% | ||
6 maanden | +49,66% | ||
Lopend jaar | +3,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Axel Bolte
FOU | Founder | 52 | 01-09-15 |
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 01-05-20 |
Director of Finance/CFO | 48 | 31-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 01-05-20 |
Reinaldo Diaz
BRD | Director/Board Member | 70 | 01-01-17 |
Axel Bolte
FOU | Founder | 52 | 01-09-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 4,4 | +0,23% | 742 573 |
22-04-24 | 4,39 | -2,66% | 813 172 |
19-04-24 | 4,51 | -1,53% | 591 071 |
18-04-24 | 4,58 | -1,51% | 561 269 |
17-04-24 | 4,65 | -4,12% | 408 256 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,29% | 272 mln. | |
+3,13% | 43,43 mld. | |
+47,41% | 41,69 mld. | |
+8,49% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+8,26% | 25,28 mld. | |
-23,69% | 18,47 mld. | |
+1,58% | 12,33 mld. | |
+32,83% | 12,59 mld. | |
+6,63% | 11,03 mld. |